AMF Tjanstepension AB Sells 39,464 Shares of Intuitive Surgical, Inc. $ISRG

AMF Tjanstepension AB cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 108,332 shares of the medical equipment provider’s stock after selling 39,464 shares during the quarter. AMF Tjanstepension AB’s holdings in Intuitive Surgical were worth $48,449,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the stock. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical during the second quarter worth about $27,000. Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical during the second quarter worth about $30,000. Riggs Asset Managment Co. Inc. grew its position in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. increased its stake in Intuitive Surgical by 3,750.0% in the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q4 results beat Wall Street: Revenue and adjusted EPS topped estimates, backed by higher procedure volumes and system demand — a primary near‑term driver of recurring instrument sales. Reuters: Intuitive Surgical beats quarterly estimates on demand for surgical robots
• Positive Sentiment: Analysts boost some targets and reaffirm conviction: Bernstein raised its target sharply (big upside), Raymond James and BTIG reaffirmed/outperform with higher targets — supporting upside potential from elongation of the company’s growth runway. Benzinga: Analysts revise forecasts after Q4
• Neutral Sentiment: Guidance is measured: Management expects mid‑teens da Vinci procedure growth (midpoint ~14%) and 2026 gross margin around 67–68%, while flagging higher operating expenses for R&D — signaling steady growth but potential margin/operating‑leverage moderation. MarketBeat: Intuitive Surgical Just Proved the Growth Engine Still Runs
• Neutral Sentiment: JURA clinical update and milestone PRs add long‑term optionality: Early imaging data from the JURA feasibility study and a new 20 million‑patient da Vinci milestone reinforce long‑term growth narratives beyond core platforms. TipRanks: JURA feasibility study update GlobeNewswire: 20 Million Patients Benefit from da Vinci Surgery
• Negative Sentiment: Tariffs and gross‑margin pressure noted: Management expects tariffs to cut gross margins (about a 1.2% headwind in 2026) and flagged some gross‑margin decline vs. recent quarters — a medium‑term profitability risk. Zacks: Q4 beat but gross margin declines
• Negative Sentiment: Mixed analyst moves and a few downgrades: Some firms trimmed targets or moved to in‑line/hold (Evercore, Zacks), creating near‑term debate over valuation vs. growth and muting upside for traders focused on short‑term catalysts. The Fly: Evercore lowers price target

Insider Buying and Selling

In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 104 shares of the business’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total value of $58,229.60. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 55,714 shares of company stock valued at $31,617,799 in the last ninety days. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Royal Bank Of Canada upped their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $617.57.

Intuitive Surgical Stock Down 0.3%

ISRG opened at $523.99 on Friday. The firm has a 50-day moving average price of $562.32 and a 200-day moving average price of $511.68. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08. The company has a market capitalization of $187.84 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 4.26 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.18%. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period last year, the firm earned $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.